Clinical feature	Statistical test	Significant genes	Associated with	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;	Associated with	
Time to Death	Cox regression test	N=0	 	 	 	 
AGE	Spearman correlation test	N=6	older	N=5	younger	N=1
PATHOLOGY T STAGE	Spearman correlation test	N=508	higher stage	N=307	lower stage	N=201
PATHOLOGY N STAGE	Wilcoxon test	N=20	class1	N=20	class0	N=0
HISTOLOGICAL TYPE	Wilcoxon test	N=14	prostate adenocarcinoma acinar type	N=14	prostate adenocarcinoma  other subtype	N=0
COMPLETENESS OF RESECTION	Kruskal-Wallis test	N=1	 	 	 	 
NUMBER OF LYMPH NODES	Spearman correlation test	N=30	higher number.of.lymph.nodes	N=16	lower number.of.lymph.nodes	N=14
GLEASON_SCORE_COMBINED	Spearman correlation test	N=1266	higher score	N=812	lower score	N=454
GLEASON_SCORE_PRIMARY	Spearman correlation test	N=1226	higher score	N=689	lower score	N=537
GLEASON_SCORE_SECONDARY	Spearman correlation test	N=108	higher score	N=84	lower score	N=24
GLEASON_SCORE	Spearman correlation test	N=1324	higher score	N=860	lower score	N=464
PSA_RESULT_PREOP	Spearman correlation test	N=111	higher psa_result_preop	N=42	lower psa_result_preop	N=69
PSA_VALUE	Spearman correlation test	N=7	higher psa_value	N=4	lower psa_value	N=3
RACE	Kruskal-Wallis test	N=0	 	 	 	 
